PTEN promoter methylation and protein expression in normal early placentas and hydatidiform moles

被引:21
作者
Chen, HZ [1 ]
Ye, DF [1 ]
Xie, X [1 ]
Lu, WG [1 ]
Zhu, CK [1 ]
Chen, XD [1 ]
机构
[1] Zhejiang Univ, Dept Oncol, Womens Hosp, Sch Med, Hangzhou 310006, Peoples R China
关键词
trophoblasts; gestational trophoblastic disease; PTEN; promoter methylation;
D O I
10.1016/j.jsgi.2005.01.009
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To investigate the relationship between PTEN promoter methylation and protein expression, and the possible involvement of the PTEN gene in development of gestational trophoblasts and the pathogenesis of hydatidiform moles. METHODS: DNA was extracted from choria of normal early placentas, partial hydatidiform moles, complete hydatidiform moles, and invasive moles, and overdigested by methylation-sensitive endonucleases HpaII. The PTEN promoter was amplificated by polymerase chain reaction. PTEN protein expression was detected by immunohistochemistry. RESULTS: In partial and complete hydatidiform moles, the PTEN promoter methylation rate was significantly higher than in early placentas (72%, 59.4%, 14.3%; P = .000, .002, respectively), and the PTEN protein expression rate was significantly lower than in early placentas (9.1%, 4.5%, 90.5%; P =. 000,. 000, respectively). However, partial hydatidiform moles, complete hydatidiform moles, and invasive moles were not significant different in terms of PTEN promoter methylation and protein expression. CONCLUSIONS: These findings suggest that the regulation of PTEN expression may play an important role in the development of the early gestational trophoblast and in the pathogenesis of hydatidiform mole, but not in its malignant tran. formation. Copyright (c) 2005 by the Society for Gynecologic Investigation.
引用
收藏
页码:214 / 217
页数:4
相关论文
共 26 条
  • [1] RELAXATION OF IMPRINTING IN TROPHOBLASTIC DISEASE
    ARIEL, I
    LUSTIG, O
    OYER, CE
    ELKIN, M
    GONIK, B
    RACHMILEWITZ, J
    BIRAN, H
    GOSHEN, R
    DEGROOT, N
    HOCHBERG, A
    [J]. GYNECOLOGIC ONCOLOGY, 1994, 53 (02) : 212 - 219
  • [2] Ariel I, 2000, AM J MED GENET, V91, P46, DOI 10.1002/(SICI)1096-8628(20000306)91:1<46::AID-AJMG8>3.0.CO
  • [3] 2-I
  • [4] PTEN, a unique tumor suppressor gene
    Dahia, PLM
    [J]. ENDOCRINE-RELATED CANCER, 2000, 7 (02) : 115 - 129
  • [5] RAS P21 EXPRESSION IN THE PROGRESSION OF BREAST-CANCER
    FROMOWITZ, FB
    VIOLA, MV
    CHAO, S
    ORAVEZ, S
    MISHRIKI, Y
    FINKEL, G
    GRIMSON, R
    LUNDY, J
    [J]. HUMAN PATHOLOGY, 1987, 18 (12) : 1268 - 1275
  • [6] Guldberg P, 1997, CANCER RES, V57, P3660
  • [7] Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 gene
    Hwang, PH
    Yi, HK
    Kim, DS
    Nam, SY
    Kim, JS
    Lee, DY
    [J]. CANCER LETTERS, 2001, 172 (01) : 83 - 91
  • [8] Kane MF, 1997, CANCER RES, V57, P808
  • [9] Promoter methylation and silencing of PTEN in gastric carcinoma
    Kang, YH
    Lee, HS
    Kim, WH
    [J]. LABORATORY INVESTIGATION, 2002, 82 (03) : 285 - 291
  • [10] PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
    Li, J
    Yen, C
    Liaw, D
    Podsypanina, K
    Bose, S
    Wang, SI
    Puc, J
    Miliaresis, C
    Rodgers, L
    McCombie, R
    Bigner, SH
    Giovanella, BC
    Ittmann, M
    Tycko, B
    Hibshoosh, H
    Wigler, MH
    Parsons, R
    [J]. SCIENCE, 1997, 275 (5308) : 1943 - 1947